Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer

Study ID
NCT00010062

Study type
Interventional

Study phase
Phase 2

Study status
Unknown status

Trial Acronym

Trial Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells left after surgery. PURPOSE: Phase II trial to study the effectiveness of combining fluorouracil and radiation therapy in treating patients who have undergone surgery for pancreatic cancer.

More informations

Trial Starting Date

Oct 31,2000

Requirements

Gender All
Minimum age 18 Years
Maximum age 75 Years

Enrollement Limit